Search

everythinglearnresearchcommunity

for

Search:↓

Certain genetic variations in the SHBG gene are linked to an increased or decreased risk of PCOS in Mediterranean women.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

Changes in testosterone and estrogen receptor genes can affect how men age, influencing body fat, hair patterns, and possibly leading to skin disorders.

Testosterone therapy can improve sexual satisfaction and mood in surgically menopausal women when used with estrogen, but its long-term safety and effects on naturally menopausal and premenopausal women are unclear.

Men with advanced liver disease and high oestrone and low testosterone levels have worse health outcomes.

Equilibrium dialysis can accurately measure testosterone levels when lab results are inconsistent.

Men with male-pattern baldness have more androgen receptors in their scalp's oil glands, which may contribute to hair loss.

The treatment effectively reduced hair growth and was safe for patients with PCOS, but it needs better bleeding control.

Testosterone therapy can help improve sexual desire and function in postmenopausal women but may cause side effects and is not FDA-approved for this use.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

A postmenopausal woman's facial redness, acne, and excess hair were caused by too much hormone therapy for insomnia, but improved after stopping the treatment.

High testosterone increases heart disease risk in women with PCOS.

Men with coeliac disease may have hormone imbalances that could affect sexual function, but these can improve with better gut health.

Androgens affect many aspects of female health, and more research is needed to understand their roles and treatment potential.

Women with persistent acne and high levels of antimullerian hormone are more likely to have polycystic ovarian syndrome.

Testosterone replacement may help postmenopausal women with sexual function and bone density, but suitable treatments are limited.

Birth control pills can cause skin issues but may help with acne and hirsutism, and choosing the right type can minimize side effects.

Chemotherapy caused a woman's permanent hair loss and early menopause.

New treatments for male hypogonadism are effective and should be personalized.

Flutamide effectively reduced excessive hair growth and improved related symptoms in hirsutism patients without significant side effects.

Hormone treatment for transgender patients may not need to be stopped before surgery, but more research is needed, especially on estrogen.

Menopause and aging can affect women's quality of life and sexuality, but hormone therapies may help alleviate these issues.

Spironolactone can reduce hair growth and testosterone in hirsutism, but is less effective than combined treatments.

Changes in SHBG levels don't predict diabetes risk reduction.

Combination therapy with oral contraceptives and spironolactone improves hair growth, menstrual issues, and acne in women with PCOS.

HSD3B1 gene variant and being overweight linked to hair loss in women with polycystic ovary syndrome.

Certain genetic variants increase the risk of resistance to hormone therapy in prostate cancer patients.

The conclusion is that adult males with muscle weakness and hormonal imbalances should be tested for Kennedy's disease.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.